ACRS

Stock Alert: Aclaris Therapeutics Up 40%

(RTTNews) - Shares of Aclaris Therapeutics, Inc. (ACRS) are currently gaining nearly 40% on Monday morning despite no stock-specific news. Pharma companies are performing better on Monday as investors are more interested in the industry on the back of positive reports of COVID-19 vaccine.

ACRS is currently trading at $3.08, up $0.87 or 39.37%, on the Nasdaq.

Aclaris Therapeutics is a biopharmaceutical company focused on developing drug candidates for immuno-inflammatory diseases in the US. It operates in two segments, Therapeutics and Contract Research.

Meanwhile, a coronavirus vaccine the University of Oxford is developing with AstraZeneca demonstrated promising results in early human testing.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.